Correspondence regarding a published study: Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials

Cardiovasc Revasc Med. 2023 Dec:57:106. doi: 10.1016/j.carrev.2023.07.012. Epub 2023 Jul 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / prevention & control
  • Cholesterol
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Inflammation
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol